Paysign Inc

Paysign Inc(PAYS)股票分析

$12.890

-0.264 (-2.05%)收盘时

Loading chart…
High
13.190
Open
13.100
VWAP
12.91
Vol
727.81K
Mkt Cap
212.44M
Low
12.650
Amount
9.40M
EV/EBITDA, TTM
15.31

Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers.

paysign.com

AI analysis of Paysign Inc (PAYS)

buy

Paysign Inc is a good buy right now due to its strong recent performance, including a Q2 GAAP EPS of $0.11, which beat expectations by $0.05, and a revenue of $28.25 million, reflecting a 48.1% year-over-year increase. The forward P/E ratio is 55.25, indicating growth potential, while the gross margin is projected to be between 62% and 63% for the full year, showcasing effective cost management. However, the main risk is the current RSI of 41.95, indicating that the stock is nearing oversold territory, which could lead to volatility in the short term.

估值指标

The current forward P/E ratio for Paysign Inc (PAYS) is 55.25, compared to its 5-year average forward P/E of 39.87.

Forward P/E

Fair
5Y Average P/E
39.87
Current P/E
55.25
高估
250.61
低估
-170.88

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
17.55
Current EV/EBITDA
15.31
高估
23.08
低估
12.01

Forward P/S

Strongly Overvalued
5Y Average P/S
3.03
Current P/S
5.58
高估
3.87
低估
2.18

Alphio AI Price Scenarios for PAYS

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PAYS

$5.83

情景价格

B

Base

Base · 50%PAYS

$5.22

情景价格

B

Bear

Bear · 25%PAYS

$3.85

情景价格

Whales holding PAYS

P

Punch & Associates Investment Management, Inc.

+ HoldingPAYS

+1.32%

3M Return

事件时间线

2026-08-05 (ET)

17:00:00

Raises FY26 Revenue Outlook to $114M-$117M

17:00:00

Paysign Reports Q2 Revenue of $28.25M

17:00:00

Sees Q3 Revenue of $28.5M-$30M

2026-05-13 (ET)

10:40:00

Sees Q2 Revenue of $26.2M-$26.7M

10:40:00

Paysign Sees 2026 Revenue Guidance of $106.5M-$110.5M

资讯

PAYS FAQ — answered by Alphio AI

Paysign, Inc. is a provider of prepaid card programs, patient affordability offerings, digital banking services and integrated payment processing designed for businesses, consumers and government institutions. The Company’s payment solutions are utilized by its corporate customers to increase customer loyalty, increase patient adherence rates, reduce administration costs and streamline operations. It markets its prepaid card solutions under its Paysign brand. Its end-to-end technologies securely enable digital payout solutions and facilitate the distribution of funds for donor compensation, copay assistance, employee rewards, travel expenses, per diem, reimbursements, rebates, and countless other exchanges of value. It operates on a payments platform with fintech capabilities that can be seamlessly integrated with its clients’ systems. It offers donor engagement app, which integrates seamlessly with existing donor management systems, delivering immediate value to plasma centers. It operates in the Industrials sector (SERVICES-BUSINESS SERVICES, NEC industry).

Paysign Inc is a good buy right now due to its strong recent performance, including a Q2 GAAP EPS of $0.11, which beat expectations by $0.05, and a revenue of $28.25 million, reflecting a 48.1% year-over-year increase. The forward P/E ratio is 55.25, indicating growth potential, while the gross margin is projected to be between 62% and 63% for the full year, showcasing effective cost management. However, the main risk is the current RSI of 41.95, indicating that the stock is nearing oversold territory, which could lead to volatility in the short term.

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

免费开始